AirFluSal

AirFluSal is owned by Sandoz Group AG, headquartered in Switzerland. No. The ultimate owner of AirFluSal, Sandoz Group AG, is headquartered in Switzerland, not in the United States.

Sandoz is a global leader in generic pharmaceuticals and biosimilars, specializing in a wide range of therapeutic areas including oncology, immunology, and respiratory health after spinning off from Novartis in late 2023.